Hanall Biopharma Q2 Operating Profit 463 Million KRW... Down 69.1% YoY

[Asia Economy Reporter Lee Gwan-joo] HanAll Biopharma announced on the 27th that its operating profit for the second quarter of this year was 463 million KRW, a decrease of 69.1% compared to the same period last year.

During the same period, sales increased by 12.0% to 26.25 billion KRW, and net loss for the period was 684 million KRW, turning to a deficit.